BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (pSer33) Peptide
BIK
Reactivité: Humain
Hôte: Synthetic
BP
-
- Antigène Tous les produits BIK
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Protein Region
- pSer33
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-BIK (pT33) Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Synonymes
- BIK Peptide, Biklk Peptide, Blk Peptide, Nbk Peptide, BIP1 Peptide, BP4 Peptide, NBK Peptide, si:dkey-31f5.6 Peptide, BCL2 interacting killer Peptide, BCL2-interacting killer Peptide, BCL2-interacting killer (apoptosis-inducing) Peptide, BIK Peptide, Bik Peptide, bik Peptide
- Sujet
- NBK, Bcl-2-interacting killer, Apoptosis inducer NBK, BIP1, BP4
- ID gène
- 638
- UniProt
- Q13323
-
Vous êtes ici:
